Quality Policy
Introduction
Corall Pharm LLC is committed to producing high-quality pharmaceutical products that meet customer and regulatory requirements. Our goal is to ensure the safety, efficacy, and reliability of our products through continuous improvement and adherence to the highest standards of quality.
Quality Objectives
- Customer Satisfaction: Achieve and maintain high levels of customer satisfaction by meeting or exceeding their expectations.
- Regulatory Compliance: Ensure all products comply with relevant regulatory requirements and standards.
- Continuous Improvement: Foster a culture of continuous improvement in all aspects of our operations.
- Employee Competence: Ensure all employees are trained and competent to perform their roles effectively.
- Risk Management: Identify and mitigate risks that could impact product quality and the effectiveness of our Quality Management System (QMS).
Product-Specific Quality Commitments
1. Syrups
Quality Characteristics: Absence of residues, unique taste and smell, completely closed packaging with labels and instructions.
Quality Control Measures: Regular testing for residues, sensory evaluation for taste and smell, and inspection of packaging integrity.
2. Tablets
Quality Characteristics: Smooth surface, normal melting time, accurate packaging according to instructions.
Quality Control Measures: Surface smoothness checks, dissolution testing, and packaging accuracy verification.
3. Suppositories
Quality Characteristics: Melting temperature of 30-34°C, homogeneous colors, no residue on packaging, packaged with instructions.
Quality Control Measures: Melting point determination, visual inspection for color uniformity, and packaging checks.
4. Powders
Quality Characteristics: Consistent particle size, free-flowing properties, accurate dosage.
Quality Control Measures: Particle size analysis, flowability testing, and dosage accuracy checks.
5. Ampoules
Quality Characteristics: Sterility, clarity of solution, accurate volume.
Quality Control Measures: Sterility testing, visual inspection for clarity, and volume verification.
6. Capsules
Quality Characteristics: Uniform fill weight, intact capsule shells, accurate labeling.
Quality Control Measures: Weight uniformity testing, inspection for shell integrity, and label accuracy checks.
Quality Characteristics: Absence of residues, unique taste and smell, completely closed packaging with labels and instructions.
Quality Control Measures: Regular testing for residues, sensory evaluation for taste and smell, and inspection of packaging integrity.
2. Tablets
Quality Characteristics: Smooth surface, normal melting time, accurate packaging according to instructions.
Quality Control Measures: Surface smoothness checks, dissolution testing, and packaging accuracy verification.
3. Suppositories
Quality Characteristics: Melting temperature of 30-34°C, homogeneous colors, no residue on packaging, packaged with instructions.
Quality Control Measures: Melting point determination, visual inspection for color uniformity, and packaging checks.
4. Powders
Quality Characteristics: Consistent particle size, free-flowing properties, accurate dosage.
Quality Control Measures: Particle size analysis, flowability testing, and dosage accuracy checks.
5. Ampoules
Quality Characteristics: Sterility, clarity of solution, accurate volume.
Quality Control Measures: Sterility testing, visual inspection for clarity, and volume verification.
6. Capsules
Quality Characteristics: Uniform fill weight, intact capsule shells, accurate labeling.
Quality Control Measures: Weight uniformity testing, inspection for shell integrity, and label accuracy checks.
Quality Management System (QMS)
Our QMS is designed to comply with ISO 9001:2015 requirements and includes the following key elements:
1. Leadership and Commitment
Top management demonstrates leadership and commitment to the QMS by ensuring the quality policy and objectives are established and aligned with the strategic direction of the company.
2. Planning
We plan our QMS to address risks and opportunities, set quality objectives, and plan changes to ensure the integrity of the QMS.
3. Support
We provide the necessary resources, including competent personnel, infrastructure, and a suitable work environment, to ensure the effective operation of the QMS.
4. Operation
Our manufacturing process includes the production of syrups, tablets, suppositories, powders, ampoules, and capsules. Each product type has specific quality characteristics that are monitored and controlled.
5. Performance Evaluation
We monitor, measure, analyze, and evaluate the performance of our QMS through internal audits, customer feedback, and management reviews.
6. Improvement
We are committed to continuous improvement of our QMS by addressing nonconformities, implementing corrective actions, and identifying opportunities for improvement
1. Leadership and Commitment
Top management demonstrates leadership and commitment to the QMS by ensuring the quality policy and objectives are established and aligned with the strategic direction of the company.
2. Planning
We plan our QMS to address risks and opportunities, set quality objectives, and plan changes to ensure the integrity of the QMS.
3. Support
We provide the necessary resources, including competent personnel, infrastructure, and a suitable work environment, to ensure the effective operation of the QMS.
4. Operation
Our manufacturing process includes the production of syrups, tablets, suppositories, powders, ampoules, and capsules. Each product type has specific quality characteristics that are monitored and controlled.
5. Performance Evaluation
We monitor, measure, analyze, and evaluate the performance of our QMS through internal audits, customer feedback, and management reviews.
6. Improvement
We are committed to continuous improvement of our QMS by addressing nonconformities, implementing corrective actions, and identifying opportunities for improvement
Commitment to Quality
Corall Pharm LLC is dedicated to maintaining the highest standards of quality in all our products and processes. We strive to build long-term relationships with our customers by consistently delivering products that meet their needs and expectations.
Effective from: 01 November 2024.
Shavkatbek Sadikov
General Director, CORALL PHARM
Shavkatbek Sadikov
General Director, CORALL PHARM
